FDA approves a cholesterol pill unlike anything before
The Food and Drug Administration has approved Lipfendra, the first oral PCSK9 inhibitor for treating high cholesterol, including a genetic form known as familial hypercholesterolemia. Manufactured by Merck, the once daily pill offers patients an alternative to the injectable versions of this drug class that have been available for years, and it is expected to […]
Opioid crisis response takes a new form as non-addictive pain drugs gain real ground
Opioid dependence has shaped chronic pain treatment for decades, with pain treated primarily as a symptom of physical damage, something to be managed with drugs that dulled the signal without addressing what was generating it. That understanding has shifted considerably. Researchers now recognize chronic pain as a complex condition involving disrupted pain processing in the […]
Chronic pain relief just got a major upgrade as the FDA approves a landmark non-opioid drug
Chronic pain affects hundreds of millions of people worldwide, and for decades opioids have been among the most widely prescribed tools for managing it, despite well-documented risks of addiction and dependency. That landscape is shifting. A wave of new pharmacological approaches, non-drug therapies and digital interventions is reshaping how clinicians think about pain relief, and […]
Is retatrutide more effective than Ozempic for weight loss
Retatrutide still experimental and not yet approved by the U.S. Food and Drug Administration, the medication is already reshaping the way researchers think about weight loss medicine. Here is what experts currently know about it. Now, a newer drug is quietly generating some of the most significant buzz in clinical research. By now, most people […]